Liver Cancer Treatment

Liver Cancer Treatment

What is hepatocellular carcinoma?

Liver cancer or hepatocellular carcinoma (HCC) is among of the common malignant tumours in the world, with a global increasing annual incidence, as reported recently. Almost half of this increase has been attributed to hepatitis C virus (HCV), while a minimal or no increase has been related to hepatitis B virus (HBV) or alcoholic liver disease. Untreated HCC has a notoriously poor prognosis, with a median survival of one to eight months and a five year survival of around 3%.

What are the treatment options for liver cancer?

Potentially curative surgical therapeutic options:

  • Partial hepatic resection of HCC with adequate margins
  • Liver transplantation for HCC

(However, only 30% to 40% of patients with HCC qualify for surgery, mostly due to advanced disease at presentation and poor hepatic function, rendering the majority of patients eligible only for palliation)

Non-surgical palliative treatment options:

 
  • ECHO
  • ECHO
  • APASL
  • Acuteon
  • DORSO
  • NSI
  • HBSCE

Copyright © Institute of Liver & Biliary Sciences 2016. All rights reserved. Designed & Developed by Cyfuture